Roberto Vettor
Current Accademic Position: Full Professor of Internal Medicine;Head, Clinica Medica 3;
Chairman, Department of Medicine-DIMED,University of Padua. ITALY
1981 Specialization in Endocrinology at Padua Medical School, Italy.
1984 Specialization in Nuclear Medicine at Padua Medical School, Italy.
1991 Specialization in Internal medicine at Padua Medical School Italy.
1992-1994 Visiting Professor at Departement of Medicine, Laboratoires de Rechercher Metabolique -Geneva University -Switzerland.
Head of the Bariatric Unit of Chief of the Centre for the Study and Integrated Therapy of Obesity. Metabolic Diseases and Cardiovascular Risk Unit, Clinical Endocrinology Unit and Endocrine-Metabolic Lab. The Centre for the Study and Integrated Therapy of Obesity has been accredited as an EASO (European Society for the Study on Obesity) Collaborating Center for Obesity Management.
PastPresident of the Italian Society for Studies of Obesityand member of Italian Diabetes Society, Italian Endocrinology Society, Internal Medicine Society, European Association for Studies on Diabetes, Endocrine Society.Founding member of the European Chapter of the AmericanCollege of Clinical Nutrition. Directorof the Specialization School ofInternal Medicine–University of Padua.
Brief Report of Research:
The main topics are the studies on the pathohysiology of obesity and type 2 diabetes and their complications. Since 1990 he coordinates a research team working on neuroendocrine control of glucose and lipid metabolism and on the molecular biology of adipose tissue. Over the last several years he has performed a significant amount of original research on the relationship between muscle, adipose tissue and the development of insulin resistance.
Another important basic and clinical research area is devoted to neuroendocrinology, specifically, the treatment of pituitary tumours and neuroendocrine tumours. The laboratory focuses on the cellular and molecular mechanisms underlying the effect of somatostatin, dopamine and their analogues in neoplastic cells of neuroendocrine origin. The clinical and therapeutical aspect of polycystic ovary syndrome.
He participated to several clinical and experimental trials both in phase 2 and 3 in GCP.He has been invited as both chair and speaker to numerous conferences and congresses around the world. He has published widely in the area of diabetes and obesity with 382original papers and several book chapters. Sum of Times Cited without self-citations: 14122, h-index:61.
